Login / Signup

Annual eradication rate of bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: A 15-year prospective study at a tertiary hospital in Korea.

Kichul YoonNa Young KimJung Won LeeHyuk YoonCheol Min ShinYoung Soo ParkDong Ho Lee
Published in: Helicobacter (2020)
Despite high antibiotic resistance rates, no significant reduction in annual eradication rates was observed during the study period.
Keyphrases
  • helicobacter pylori infection
  • helicobacter pylori
  • replacement therapy
  • mesenchymal stem cells
  • oxide nanoparticles